I am designing a plasmid in VectorBuilder, and it automatically assigns the CMV promoter (Human cytomegalovirus immediate early enhancer/promoter) for shRNA expression. However, in our lab, we have a scramble control plasmid that is identical to my designed vector, except that it uses the RSV promoter (Rous sarcoma virus enhancer/promoter) instead of CMV.
Would this difference in promoters pose any issues in terms of experimental validity, gene knockdown efficiency, or data interpretation? Can I use it as my scramble control?